TIGIT and neoplasm: Additionally, CyTOF analysis of tumour samples revealed expression of immune checkpoint (IC) molecules, particularly TIGIT and PD-1 in infiltrating T cells, suggesting a pre-existing immune response, providing the rationale for combination therapy with IC inhibitors and Gsα peptide vaccine in PMP.